Search hospitals > Michigan > Ann Arbor
C S Mott Children's Hospital
Claim this profileAnn Arbor, Michigan 48109
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Neuroblastoma
Conducts research for Solid Tumors
Conducts research for Relapse
370 reported clinical trials
23 medical researchers
Summary
C S Mott Children's Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Neuroblastoma, Solid Tumors, Relapse and other specialties. C S Mott Children's Hospital is involved with conducting 370 clinical trials across 601 conditions. There are 23 research doctors associated with this hospital, such as Rajen Mody, MD, MS, Carl Koschmann, MD, Rama Jasty, and Emily B. Walling.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global LeaderStage II
NTRK1 positive
NTRK positive
Top PIs
Rajen Mody, MD, MSC S Mott Children's Hospital8 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
52 reported clinical trials
85 drugs studied
Carl Koschmann, MDUniversity of Michigan3 years of reported clinical research
Studies Brain Tumor
Studies Brain Cancer
11 reported clinical trials
18 drugs studied
Rama JastyC S Mott Children's Hospital7 years of reported clinical research
Studies Cancer
Studies Rhabdomyosarcoma
11 reported clinical trials
28 drugs studied
Emily B. WallingC S Mott Children's Hospital5 years of reported clinical research
Studies Adult T-Cell Leukemia/Lymphoma
Studies Acute Lymphoblastic Leukemia
11 reported clinical trials
41 drugs studied
Clinical Trials running at C S Mott Children's Hospital
Brain Tumor
Cancer
Acute Lymphoblastic Leukemia
Wilms Tumor
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Testicular cancer
Childhood Leukemia
Neuroblastoma
Testicular Carcinoma
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
DAY101 vs. Chemotherapy
for Pediatric Brain Cancer
This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at C S Mott Children's Hospital?
Where is C S Mott Children's Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does C S Mott Children's Hospital accept?
What awards or recognition has C S Mott Children's Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.